Appearing as a promising advance in the struggle against obesity, Retatrutide is generating considerable buzz. It combines properties of two recognized GLP-1 receptor agonists, liraglutide, with an additional glucose-dependent hormonal component. Initial clinical results have indicated significant weight loss in patients with excessive weight, … Read More